167
Participants
Start Date
October 25, 2016
Primary Completion Date
August 10, 2017
Study Completion Date
January 31, 2019
Upadacitinib
Tablet for oral use
Placebo
Tablet
St George Hospital /ID# 157908, Kogarah
Woden Dermatology /ID# 157907, Phillip
Skin Health Institute Inc /ID# 157906, Carlton
Specialist Connect Pty Ltd /ID# 157909, Woolloongabba
Icahn School of Med Mt. Sinai /ID# 153582, New York
Univ Rochester Med Ctr /ID# 154477, Rochester
TFS Trial Form Support GmbH /ID# 155442, Hamburg
Mehiläinen Neo /ID# 154960, Turku
DermAssociates /ID# 153584, Rockville
Mikkeli Central Hospital /ID# 154959, Mikkeli
Modern Research Associates, PL /ID# 154487, Dallas
Arlington Research Center, Inc /ID# 154522, Arlington
Center for Clinical Studies /ID# 153589, Houston
ForCare Clinical Research /ID# 157974, Tampa
Advanced Medical Research /ID# 154516, Sandy Springs
Tufts Medical Center /ID# 153586, Boston
Psoriasis Treatment Ctr NJ /ID# 153578, East Windsor
Institute for Skin Advancement /ID# 153246, Calgary
Dr. Chih-ho Hong Medical Inc. /ID# 153241, Surrey
Enverus Medical Research /ID# 153239, Surrey
CCA Medical Research /ID# 155817, Ajax
Lynderm Research Inc. /ID# 153242, Markham
Dermatology Ottawa Research Centre /ID# 153248, Ottawa
K. Papp Clinical Research /ID# 153244, Waterloo
Fukuoka University Hospital /ID# 152714, Fukuoka
Takagi Dermatological Clinic /ID# 152706, Obihiro-shi
Medical Cooperation Kojinkai Sapporo Skin Clinic /ID# 153781, Sapporo
Nippon Medical School Hospital /ID# 153287, Tokyo
Radboud Universitair Medisch Centrum /ID# 153688, Nijmegen
Academisch Medisch Centrum /ID# 153596, Amsterdam
Universitair Medisch Centrum Groningen /ID# 153595, Groningen
Universitair Medisch Centrum Utrecht /ID# 153687, Utrecht
Hospital Santa Creu i Sant Pau /ID# 153519, Barcelona
Hospital Univ Germans Trias I /ID# 155598, Barcelona
Lead Sponsor
AbbVie
INDUSTRY